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During its 25 years of existence, the National Institute on

Alcohol Abuse and Alcoholism (NIAAA) has been influenced by many individuals and

organizations. Among those shaping NIAAA’s missions and their implementations, the Institute’s

directors played and continue to play a pivotal role. In return, the position as director of

NIAAA had an impact on these men and their careers. Alcohol Health & Research World
 
contacted the former and current directors to record their personal recollections

and impressions of the alcohol field and NIAAA’s role in it.
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problem being faced by the country. This But people who have suffered an illnessMORRIS E. 
CHAFETZ, M.D. 
DIRECTOR, 1971–1975	 
AH&RW: Dr. Chafetz, how did you get
involved in the alcohol field? It was not 
really a popular field in the 1960’s and
1970’s. 
Chafetz: No, it certainly was not. What got
me into the field on July 1, 1954, was pure
opportunism. I had finished my training at
Harvard Medical School and Massachu­
setts General Hospital and there was no
job available except one. The State had
given Massachussetts General Hospital
money to start an alcoholism clinic, and no
other psychiatrist would take the job. I did
not think much of alcoholic people. I did
not like them; I just was not the least bit
interested in them. But I loved the hospital
and I wanted to stay there. And it only took
me a few months of listening to these
patients to recognize my prejudices and the
prejudices of others. I realized that this
issue reflected every social health policy 
realization is why I have enjoyed working tend to be subjective and judge the problem
in the field for 41 years and still enjoy it. only from their experiences. Because I was 
AH&RW: Before you became the first
director of the National Institute on Alcohol 
Abuse and Alcoholism (NIAAA), were
you also involved in the lobbying process
for the legislation that established the
new Institute? 
Chafetz: Well, I testified before Senator
Harold Hughes’ committee when it was
preparing the legislation in 1970.1 I repre­
sented the American Psychiatric Asso­
ciation. As you can imagine, there were
very few people who were interested in
the legislation. The only people who were
really interested in the issue were people
who had had alcohol problems themselves
or in their family. I didn’t qualify for that. 
1Senator Harold Hughes was chairman of the
Subcommittee on Alcoholism and Drug Abuse in
1969/1970, which drafted Public Law 91–616. This
law, among other things, established NIAAA. The
Senate approved the bill on August 10, 1970, and the
House of Representatives followed on December 18,
1970. President Richard Nixon signed the bill into
law on December 31, 1970. 
MORRIS E. CHAFETZ, M. D., was
NIAAA’s first director. After leaving
the Institute, Dr. Chafetz founded the
Health Education Foundation, an
organization that focuses on the
relationships between lifestyles and
health. He still serves as the presi­
dent of the foundation. In addition,
Dr. Chafetz served on President 
Reagan’s Presidential Commission
on Drunk Driving. 
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not personally affected by alcoholism, I
could take what I felt was a more objec­
tive perspective. For example, I remember
that when Marty Mann2 first heard me 
speak in 1959, she said, “I disagree with
everything that you’ve just said, but for
the sake of the field, please keep saying
it.” Also, when I testified, Senator
Hughes—who himself had recovered
from alcoholism—asked me some critical 
questions and he was startled by my candor
in responding to them. We became fast
friends after the hearings.
In September 1970 I took a position
in what was then the Division on Alco­
holism at the National Institute of Mental 
Health (NIMH), so officially I could not
lobby for the alcohol legislation. But that
didn’t mean I did not quietly work very
hard to have it passed. On December 18,
1970, I was in the gallery with my wife
when the bill was passed in the House of
Representatives, and I went down and
hugged Congressman Paul Rogers who
had steered it through. I later learned that
I should not have been present when my
bill was being considered. But I was just
too ignorant of all the rules and regula­
tions to have known that. 
Everybody then said that President
Richard Nixon would never sign the bill
because he was very much opposed to it.
I was going out of the country but I reas­
sured all my friends that “Chafetz luck”
would operate, and President Nixon finally
did sign the bill on December 31. I later
was told that he signed it without a word. 
AH&RW: What was it like to be in 
charge of establishing the new Institute? 
Chafetz: Well, as Harold Hughes said to
me, I had a one­in­a­million opportunity. I
had spent 16 years studying alcoholism in
an academic setting; I had been all over
the world studying the problem. I really
was quite immersed in it. When I was
invited to become the director, I couldn’t
pass it up, it was just an unbelievable
opportunity. Who gets the chance to start
a Federal agency in their area of expertise,
the field they have studied for years? It
really was the greatest 5 years of my life. 
AH&RW: What was NIAAA’s most 
important mission in that initial period? 
Chafetz: At that time, it was to get rid of
the stigma that was associated with alco­
2Marty Mann was the first female member of Alco­
holics Anonymous. She also founded the National
Committee for Education on Alcoholism, which later 
became the National Council on Alcoholism. 
holism. I remember that Harold Hughes
could not recruit a public figure to testify
about his or her alcohol situation. Finally,
we convinced [actress] Mercedes
McCambridge to speak. She put her
career in jeopardy by testifying. Now it
has become almost the other extreme. It 
is almost fashionable to have an alcohol 
problem and to say you are recovering
from it. But at that time, alcoholism was
so stigmatized, was so looked down on.
Having experienced the extent of my
own prejudices and my own ignorance of
the issue, I was bound and determined to
turn the country around and to treat alco­
holics as ill human beings who needed
treatment, not as bad people who should
be ignored and neglected. I remember
saying in one of my first speeches that
alcoholism was America’s most treatable,
untreated illness, and I still feel that way.
But the Institute also became involved in 
a lot of other areas. We got into preven­
tion, we got into international programs.
When I started at NIAAA, the budget
was $6.5 million. By fiscal year 1974, my
last year at the Institute, we had a staff of
only 90 employees, including secretaries,
but a budget of $214 million. At that time,
we funded everything: grants for the State
programs, education, prevention, treat­
ment, international work—you name it,
we did it. 
AH&RW: How do you think NIAAA’s
mission has changed over the years? 
Chafetz: I have studied the history of
alcoholism and alcohol research, and I
have repeatedly seen a shift in focus away
from the people and onto the drug alcohol.
I think that this is an unfortunate situation. 
I consider alcoholism and alcohol prob­
lems a people issue, a societal issue.
This shift of focus from the disease 
alcoholism to the drug alcohol is what
bothers me the most because alcohol itself 
really does not count: The issue is people.
I am a people person in all my activities.
That is why at NIAAA we started a pre­
vention program that focused on responsi­
ble drinking. That is why the foundation I
head now has developed a program with
the acronym TIPS [Training for Inter­
vention Procedures by Servers of Alcohol],
which teaches people around the drinker
to make sure that the drinker does not get
into trouble. I believe in local education;
I believe in responding to human beings.
But I have a feeling that some of the
missions of the Institute got distracted
away from the people. 
AH&RW: Do you think that the individu­
al alcoholic or health care professional
benefits from all the scientific advances 
of alcohol research? 
Chafetz: My view of alcoholism is that it
is a multidimensional illness that involves 
many facets—genetics, physiology, soci­
etal aspects, and so on. Although research
has refined some of these specific aspects
of alcoholism, I don’t believe that we
have made the progress necessary to help
us understand or successfully treat alco­
holism. It is such a multidimensional 
problem. We still do not have clear defini­
tions of alcoholism and alcohol problems.
How can we measure the outcome of a 
genetic predisposition if we do not have a
clear definition of the disease? Alcohol­
ism is not the kind of condition that lends 
itself to easy conclusions. 
AH&RW: What do you think has been
NIAAA’s most outstanding achievement
over these 25 years? 
Chafetz: The most important achieve­
ment, in my opinion, is that NIAAA has
made the country recognize that alcoholic
people are not bad but are ill and in need
of treatment. The social stigma has been
removed and people now will seek help.
There are still many things missing in the
system of providing help, but it is none­
theless an enormous success. Imagine
breaking down such a prejudice in only 25
years! That is a remarkable achievement. 
AH&RW: What has your tenure at
NIAAA meant to you personally, and
how has it affected your career? 
Chafetz: For one thing, it brought me to
Washington, DC, and I have stayed ever
since. And the time at NIAAA certainly
was the greatest professional experience
of my life. I could not have been luckier
than to have had that experience of found­
ing a Government agency.
The experience as Institute director
also gave me a new perspective—that no
matter how wonderful treatment was, it
could only contain the flood of alcohol
problems, not stop it. I realized that we
had to move to a prevention modality.
That realization motivated the prevention
program for responsible drinking at the
Institute, and it was the reason why I later
developed the TIPS program. I think that
to teach people in bars, in universities, in
grocery stores, and in the workplace, to
give them the tools to intervene and pre­
vent alcohol problems, is the way to go.
Prevention is the key and will always be 
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the focus of my activities. And when I
talk about prevention, I don’t mean lectur­
ing or putting out slogans and signs. I am
talking about people having an impact on
other people. That is how true changes in
behavior are made. My work in preven­
tion gives me almost as much satisfaction
as I experienced starting the Institute.
After I left NIAAA, I also was ap­
pointed by President Ronald Reagan as
the chairman of the Education and Pre­
vention Committee of the Presidential 
Commission on Drunk Driving. That
was a great experience as well. 
AH&RW: What direction should the 
alcohol field take over the next 25 years
in your opinion? 
Chafetz: I would hope that we would
acquire a better understanding of how we
can prevent alcohol problems. And rather
than focus on the drug alcohol, I would
like to see a focus on people. The research
should be on people, not on a substance
that has been around since the beginning
of time. ■ 
ERNEST P. NOBLE,
PH.D., M.D. 
DIRECTOR, 1976–1978 
AH&RW: Dr. Noble, can you describe
briefly how you got involved in the alco­
hol field? 
Noble: After receiving my Ph.D. in bio­
chemistry, I went to medical school at
Case Western Reserve University, where
I had some contact with alcoholics as a 
medical student. However, I really began
to appreciate the problem as a resident in
medicine at Stanford University. There, for
the first time, I saw the vast devastation
that alcohol caused in the patients. At that
time, the diagnosis rarely was alcoholism;
doctors called it liver disease, they called
it heart disease, or they called it psychosis.
But I saw that the common denominator 
among the patients was alcoholism, that
many of them were hospitalized for alcohol­
induced problems.
After I finished my residency and
became an assistant professor in psychia­
try at Stanford, I felt that I needed more
training in basic neurosciences. With a
career development award from NIMH,
I went to the laboratory of Dr. Julius
Axelrod, the future Nobel laureate, who 
got me very excited about neurotransmit­
ter systems. When I returned to Stanford,
the problems I saw in the alcoholics and
the possibility that alcohol might affect
the brain through the neurotransmitter
systems made me think that this would be
an interesting area to research. Many of
my colleagues at Stanford and elsewhere
tried to discourage me, suggesting that I
should pursue more exciting areas, such
as schizophrenia or depression. However,
I felt that I wanted to get into the alcohol
field and began to study the genetics of
alcoholism in animal models, using mice
that either did or did not prefer alcohol.
A few years later, while I was taking a
sabbatical in Strasburg, France, I received
a call saying that Dr. Morris Chafetz, the
first director of NIAAA, had resigned and
would I be interested in the position. I
thought, “Why should I? I’ve got a very
good job, I earn a good salary, and I live
in a beautiful area in California,” so I
discouraged the first caller. But then I got
a second and third call, which showed me
that this was a serious offer. Finally my
wife said, “Why don’t you put your hat
into the ring and see what happens.” So
I did. A few weeks later, I was called to
Washington, DC, for an interview and
selected to be the director. That is how I 
came to NIAAA. 
AH&RW: During your time at NIAAA,
what did you consider the Institute’s most
important program, most important mission? 
Noble: I thought two fundamental issues
had to be addressed. The first was to 
reduce the devastation caused by alco­
holism in our country. The second, which
I had more personal experience with, was
to create a substantial base of research 
and knowledge about alcohol’s and alco­
holism’s effect on the body systems.
When I became NIAAA director, the
per capita consumption of alcohol was
higher than it had ever been in the history
of our country, even higher than just
before Prohibition. As a biochemist and 
biologist, I knew that alcohol is a cytotox­
ic and addictive drug, and I saw a strong
connection between the amount Ameri­
cans drank and the kinds of alcohol prob­
lems we were faced with. This was not 
just my personal point of view, nor was
it limited to the United States. We did a 
thorough study of alcohol consumption
around the world and everywhere found
a very close relationship between the
amount of alcohol consumed and the 
problems that alcohol engendered. There­
fore, I felt that we had to develop meas­
After serving as director of NIAAA,
ERNEST P. NOBLE, PH.D., M. D., was
appointed associate administrator of
the Alcohol, Drug Abuse, and Mental
Health Administration (ADAMHA;
now called the Substance Abuse and 
Mental Health Services Adminis­
tration). Since 1981 he has been Pike
Professor of Alcohol Studies and 
director of the Alcohol Research 
Center at the University of California,
Los Angeles (UCLA). He also has
served as the director of the Alcohol 
and Drug Treatment Program at
UCLA since 1983. 
ures to decrease alcohol consumption.
This is, of course, also a political issue,
because alcohol is a socially accepted
beverage. It is a big industry, and conse­
quently, just the concept of reducing
consumption created conflicts.
I felt that we should use the public
health model as a means to mitigate the
alcohol problems in this country. This
model entailed that to diminish alcohol 
consumption, we had to consider three
factors: the host (i.e., the drinker), the
agent (i.e., alcohol), and the environment
(i.e., social attitudes toward drinking).
Along that same line, in 1977 I first
addressed fetal alcohol syndrome (FAS)
in a message to the Nation. FAS captured
the imagination of people—it was a prob­
lem we could prevent, and it demonstrat­
ed for the first time that the agent alcohol
itself caused the damage. The efforts to
prevent FAS have progressed rather
rapidly since then. For example, research
grants were awarded by NIAAA to study
FAS, and warning labels were introduced,
not only on [alcoholic beverage] bottles
but also in bars in some States. Prevention 
of FAS was one project that took off
right away and that has become one of
NIAAA’s most important successes. 
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As for the second fundamental mission,
enhancing the base of knowledge, we were
able to double the research budget for the
Institute. We also established 9 alcohol 
research centers throughout the country,
which now have been expanded to 14
centers. Those programs have been very
successful in increasing the knowledge
about alcohol. 
AH&RW: Are there other areas in which 
you feel NIAAA has made important
contributions in the past 25 years? 
Noble: I think the public health model
was one of the most important ones, and
there were successful spinoffs, for exam­
ple, in terms of drinking and driving.
Once the people’s consciousness was
raised about the damage that alcohol can
induce, grass roots movements began to
sprout, such as Mothers Against Drunk
Driving, which were seeded by NIAAA
and which have become quite successful
around the country. As a result, the num­
bers of alcohol­related highway deaths
and injuries have decreased significantly.
Another success of NIAAA is the 
destigmatization of the alcohol problem.
As I mentioned earlier, during my resi­
dency at Stanford, we did not make a
diagnosis of alcoholism because of the
shame that it would bring to the patient.
Today the identification of alcoholics is
much more successful than it was then. 
The stigma is decreasing, although it still
exists; a small but significant segment of
the population still considers alcoholics
as weak­willed, morally depraved individ­
uals. The destigmatization has been
achieved through NIAAA’s efforts in
alliance with other organizations, such
as the National Council on Alcoholism 
(NCA). It is, I think, due in part to re­
search findings that show a strong genetic
component to alcoholism. If there is a
genetic predisposition to alcoholism that
people inherit, then it is not necessarily
their fault if they develop the disease, and
we should show them more compassion. 
AH&RW: Do you think the individual
alcoholic or health care professional
benefits from the scientific advances in 
the alcohol field? 
Noble: I am sorry to say that the actual
application of research knowledge to
treatment is still lagging behind. Besides
raising the awareness of FAS and drink­
ing and driving issues, we have not made
much progress in affecting alcoholics
and the care they receive. After talking to 
many health care professionals around
the country, I have the impression that the
research information that has been gath­
ered has not been transferred successfully
from the so­called bench to the bed. There 
really have not been any significant prac­
tical spinoffs for treatment. We still have
few effective pharmacological agents, and
alcoholics now are treated pretty much
as they were 20 or 30 years ago. I think
there has not been the kind of significant
progress in the treatment of alcoholism as
in areas such as heart disease during the
past decade. 
AH&RW: What do you consider the most
important alcohol­related questions for
the next 25 years? Where is the greatest
need for improvement? 
Noble: I think the greatest need for im­
provement is in really understanding what
this arcane disorder called alcoholism is 
all about. We need to understand better 
the contribution of the environment to the 
disease; we need to understand better the
contribution of genetic factors; and, per­
haps most importantly, we need to under­
stand better how these factors interact to 
cause alcoholism in some people or to
protect other people from it. That is a
fundamental question, and the only way
to answer it is through research. People
might not be pleased with all of the re­
search results, but we need objective
information instead of being moved by
our own feelings about what the disorder
alcoholism is. 
AH&RW: What was the most important
impact that your tenure as NIAAA direc­
tor had on you and your career? 
Noble: Being director of NIAAA was a
very exciting and highly rewarding expe­
rience. Before I came to NIAAA, I was a
scientist, so I mainly was involved in
research and had limited experience in the
treatment of alcoholics. As NIAAA direc­
tor, I suddenly was thrust into a national,
even international, limelight. I was ex­
pected to understand, or at least to look at,
the whole issue of alcoholism from a 
panoramic standpoint. I was the number­
one Federal representative on whose
shoulders was the responsibility to do
something about the problem. Therefore,
I wanted to really understand the problem
first hand. I traveled across the Nation; I
went to virtually every State including
Alaska; I went to the small villages; I
went to the ghetto areas, the black areas,
the Hispanic areas, the poor white areas; I 
went to women’s programs, children’s
programs, and adult programs. I got a
first­hand view of the devastation that 
alcohol causes and of what was being
done to deal with it. This exposure to the
whole range of problems that alcohol
created in our Nation was very beneficial
for me and expanded my own narrow
point of view about alcoholism.
Another personally rewarding aspect
was the interaction with Congress and the
White House. I tried to use the knowledge
that we had to educate those in higher
positions about the problems that alcohol
caused. As NIAAA director, I had to be a
spokesperson; I felt that at least I had to
put forth my ideas. Some people may not
have liked what I was saying, but it had to
be said so that we could educate people
about the importance of alcohol programs,
so that we would get more funding and
more attention to this number­one drug
problem in America. ■ 
LORAN ARCHER 
ACTING DIRECTOR,
1978–1979, 1981–1982, 
AND 1986 
AH&RW: Mr. Archer, when did you start
working at NIAAA and how did you
become involved in the alcohol field? 
Archer: I came to NIAAA in the summer 
of 1977. But I initially became involved
in the field in 1956, when I came out of
graduate school, trained as a vocational
rehabilitation counselor. My first assign­
ment was to work as a liaison for voca­
tional rehabilitation in a Veterans 
Administration hospital and a county
tuberculosis (TB) sanitarium. In the TB
clinic, I discovered quickly that many
patients were alcoholics. I became very
interested in that, because these people
came from a wide variety of backgrounds
and were not the “skid­row” alcoholics I 
typically had thought of.
Later I served in Fresno, CA, on the
board of the local TB association. At that 
time, the TB association had taken the
recently established NCA under its wing,
assisting the council in getting started in
California. That was when I first met 
[NCA founder] Marty Mann and became
very interested in her projects.
Around the same time, the national
interest in alcoholism was growing, and a 
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joint liaison at the national level was estab­
lished between vocational rehabilitation 
and the alcoholism programs. California
also created such a position, and I became
the liaison to the California Department of
Public Health, which was responsible for
the alcohol programs. There I was influ­
enced by Dr. A.C. Hollister, an epidemiol­
ogist who headed California’s alcohol
program. I held that position for a little
over a year and helped develop a special­
ized vocational rehabilitation program for
alcoholics. The responsibility for alco­
holism treatment programs subsequently
was transferred completely to the vocation­
al rehabilitation department, and I became
the director of California’s alcoholism 
prevention and treatment programs. That
was probably one of the most exciting and
educational times for me, because I had
complete freedom to pursue some innova­
tive ideas. For example, in an effort to
reach employed clients, we established
treatment programs that stayed open in
the evenings.
In 1977 Dr. Ernest Noble, who had
become director of NIAAA in 1976,
invited me to come to the Institute to 
work as an executive assistant with him. 
When Dr. Noble left the Institute in 1978,
I became the acting director. That is how I
became involved with NIAAA, which is a
somewhat strange way. But I think people
came into the alcohol field from a wide 
variety of directions. 
AH&RW: That was the first of your three
tenures as acting director? 
Archer: Yes, I was actually never direc­
tor, always acting director. But I was very
fortunate, because each time I received
very strong support from the administra­
tors of ADAMHA3 and thus had good
authority. Also, I discovered that the
acting director tended to stay at the Insti­
tute, whereas the directors left to take on
other positions. And because I enjoyed
being at NIAAA and wanted to continue
working in the alcohol field, I was pleased
to stay in my position as deputy director. 
AH&RW: After your lengthy experience
at NIAAA, what do you think are the
unique characteristics that have enabled
the Institute to spearhead the advances in
alcoholism research, treatment, preven­
tion, and so on? 
3ADAMHA was the umbrella organization for
NIAAA and two other Institutes of the National 
Institutes of Health from 1973 to 1993. 
LORAN ARCHER received his initial 
training as a vocational rehabilita­
tion counselor. Prior to coming to
NIAAA, he served in various posi­
tions in California’s alcohol 
programs, including director of
California’s alcoholism prevention
and treatment programs. Mr. Archer
worked at NIAAA from 1977 up to
his retirement in 1993. 
Archer: For one thing, the Institute has
been very fortunate in terms of outside
support. Several secretaries of the Depart­
ment of Health, Education, and Welfare
(now called the Department of Health and
Human Services) were very interested in
alcoholism. Most of them were not in 
positions to help the Institute much fiscal­
ly, but they were able to provide political
support. The same applies to the surgeon
generals. Working with some of them
probably was one of the most fortunate
experiences I have had, particularly with
Dr. Everett Koop, who was very innova­
tive, aggressive, and willing to commit his
time and effort to the alcohol field. 
Another very important factor for the
Institute’s success is that NIAAA always
has been willing to keep a very broad
view of all the aspects of alcohol prob­
lems instead of focusing on any single
biological or social model of alcoholism.
The Institute has supported research in
areas from molecular biology to macro­
economics. This versatility has allowed,
and hopefully will continue to allow, the
Institute to provide good research infor­
mation on which public policy can then
be based. This has been true for public
policy issues related to biological or
medical aspects of alcoholism, such as
questions on liver transplants; for issues
of health care utilization; and for issues
of health insurance. NIAAA was at the 
forefront of the initial effort to provide
health insurance coverage for alcoholism.
And if and when a national health insur­
ance system ever is established, NIAAA
hopefully will have the research informa­
tion to assist in devising a public policy
that includes adequate alcoholism preven­
tion and treatment. 
AH&RW: Lately, much of the Institute’s
focus appears to be on the molecular
biology aspects of alcoholism. 
Archer: I don’t think molecular biology is
necessarily a focus of NIAAA. Molecular
biology is exciting in every biomedical
area, whether it is cancer, arthritis, cystic
fibrosis, or alcoholism. Consequently,
molecular biology gets a lot of press
coverage. But when you look at what the
Institute actually is doing, there are many
other projects going on that will continue
to be important. People do not get as
excited about some of the other aspects of
alcoholism, but then, molecular biology
too may not be as exciting in a few years.
At the moment, we are going through a
period where knowledge about genes in­
volved in alcoholism and other diseases is 
developing very rapidly. The danger is that
we get so preoccupied with the genetics that
we assume that genes are the total cause of
alcoholism. We have to remember that 
genes are only one aspect of alcoholism and
that the environment also plays an important
role. I think the Institute very successfully
has kept a balanced view and has empha­
sized that although there may be aspects of
alcoholism that are genetically determined,
the environment also is a major contributor. 
AH&RW: In your opinion, how have the
developments and scientific breakthroughs
in the alcohol field affected the individual 
alcoholic? 
Archer: The alcohol field, like many oth­
ers, changes only slowly. There is no dra­
matic jump, no fast change in paradigms.
But when you look back 10 or 20 years,
you notice that there are little changes. It is
much like what is going on with smoking.
People watching movies from the 1930’s
are struck by what seems to be very unusu­
al behavior, namely many people smoking.
We notice it because there has been a major
change in behavior. The same is happening
with alcohol. People who have been in­
volved with Alcoholics Anonymous (AA)
and other organizations for a long time say
that in the 1930’s, they felt a public pres­
sure to drink. Today public attitudes toward
drinking have changed, and abstinence is
an acceptable behavior. That has been one
of the most important changes that I have 
VOL. 19, NO. 1, 1995 21 
seen happen, and the Institute has been at
the forefront of this development.
After its creation, the Institute had the
main responsibility for establishing the
infrastructure for treatment and prevention
programs at the State and local levels.
After that was done very successfully, the
responsibility for these programs was
transferred to local communities and the 
States. NIAAA also took the lead in estab­
lishing programs with business, such as
employee assistance programs, which
identify people with alcohol problems
early, and in getting alcoholism treatment
included as a part of general health insur­
ance. These developments have made a
major difference for the individual alcoholic. 
AH&RW: What do you consider the most
important objectives for NIAAA for the
next 25 years? 
Archer: I think that we still have major
needs concerning adequate prevention and
identification of alcohol problems. We still
have large numbers of individuals who
have alcohol­related problems, and we
need to do a better job in preventing these
problems. The effectiveness of treatment
will continue to improve as we learn more
and develop innovative approaches, but I 
JOHN R. DELUCA, now deceased, was
director of NIAAA from 1979 until 
1981. When once asked for his 
reflections on NIAAA’s activities 
during its early years, DeLuca replied, 
There have been a number of 
specific advances since 1971,
but perhaps the most significant
achievement is the greater
maturity that now guides this
public health effort. This is
apparent in the greater depth
and breadth of understanding of
those within the field, and in a
more sophisticated understand­
ing of alcoholism by the public.
This maturity has brought us a
deepened appreciation of the
complexity of the disease, and
has enabled us to discard many
myths that once affected our
responses to it. The veil of
shame that in the past surround­
ed alcoholism is being lifted,
allowing us to see it as a treat­
able disease and not as a failure 
of character. 
(DELUCA, J.R. Editor’s Forum. Alcohol
 
Health & Research World 12(4):268–
 
277, 1988)
 
think the greatest need for improvement
will be in the area of prevention. We need
better information about who is most 
highly at risk of becoming alcoholic. Right
now we are using very broad measures of
high risk. For example, we have known for
a long time that the highest risk group is
family members of alcoholics, but that is
such a rough measure; many children of
alcoholics never become alcoholic them­
selves. So far we do not know how to 
identify individuals at risk more accurate­
ly. But we hope to develop some criteria
out of the major ongoing studies, such as
the Cooperative Agreement on Genetics of
Alcoholism (COGA) or the large­scale
genetic studies.4 
AH&RW: What did your work at NIAAA
mean to you personally, especially since
you were with the Institute for so many
years? 
Archer: For me, the alcohol field was
exciting and a lot of fun to work in. I have
had the opportunity to work with some
very interesting people, from Dr. Hollister
in the California Department of Public
Health to all the different NIAAA direc­
tors. Each one of them was a different 
personality and enjoyable to work with.
The work also gave me a lot of person­
al satisfaction. I saw treatment improve
and become more available. I saw a 
change in society, which I thought the
Institute contributed to, toward making
recovery more acceptable. I saw some
positive aspects in my own personal
knowledge of people who have recovered
from alcoholism. And now that I have 
retired, I have the time and the freedom to
work in an emeritus type of situation on
some questions that I have always had. It
was rewarding being in the administra­
tion, but it did not give me the opportuni­
ty to really delve into some of the
research questions. I hope that some of
the things my colleagues and I are looking
at now can have some impact and useful­
ness in the public policy arena. We still
need to know more about many areas that
will affect public policy, such as the
economic aspects of alcoholism, ques­
tions about raising taxes [on alcohol], and
questions on high­risk individuals. ■ 
4COGA is a multidisciplinary study involving seven
research institutions throughout the country that is
attempting to elucidate genetic components of the
vulnerability to alcoholism. Other genetic studies
funded by NIAAA focus on brain functions and alcohol
metabolism both in humans and in animal models. 
WILLIAM E. 
MAYER, M.D. 
DIRECTOR, 1982–1983 
AH&RW: Dr. Mayer, can you tell me a
little bit about how you got started in the
alcohol field? 
Mayer: I was trained in psychiatry, finish­
ing my senior residency at the Langley
Porter Neuro­Psychiatric Institute in San
Francisco in early 1950. At that time,
psychiatry was still not widely used by
the general public, and people were pretty
uneasy about it. Those of us who wanted
to start a private practice had to rely
entirely on referrals from senior faculty
members of medical institutions. I had a 
good relationship with several senior
faculty members, and they started sending
me patients.
In my practice, I discovered a couple
of things right away. One was that many,
if not most, of my patients had serious
alcohol problems. And these were people
who were working, who were making a
living, who were socially acceptable, and
so on. The second observation was that 
the patients did not seem to improve with
the psychoanalytically based psychothera­
py that I was doing. It didn’t dawn on me
then that what we had been taught until
then—that alcoholism was a character and 
behavior disorder, that it represented
deficient moral strength, or that it was a
manifestation of an underlying psychiatric
problem—perhaps was not correct.
That was the beginning of my involve­
ment with the alcohol field. In the 
mid­1960’s, I worked for the California
community mental health system, which in
those days was very progressive, and I
developed a community mental health
program in Eureka, CA. Among our pa­
tients were many alcoholics, whom we
treated not as if they were neurotic or had a
character disorder but as if they had a
chronic physical disease. We discovered
that if we were genuinely nonjudgmental,
the alcoholics developed a trustful relation­
ship with us, kept coming back, and had
longer and longer periods of abstinence.
Through those experiences, I became
utterly convinced, which I am to this day,
that once you have developed the disease
alcoholism, you can never, ever, under any
circumstances, consume any kind of alco­
hol without serious risk of harm. We 
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taught that to the patients, and we were
extremely successful with the program.
Subsequently I became first the chief
deputy and then the director of the
California Department of Mental Hygiene
and finally the overall health commission­
er in California. In the latter position, I
saw a wide variety of approaches to the
treatment of alcoholics in the community,
most of which were not very effective. I
increasingly became convinced that the
only demonstrably successful long­term
management and the only way to maintain
a normal life for most alcoholics was to 
be very active in AA, and I continue to
believe that today.
Later I spent 3 years in Germany
running an alcoholism treatment facility
located at an army medical center. There
we treated a vast array of people with
alcohol problems, including people in
extremely responsible positions, even an
officer in charge of a nuclear artillery
unit. I also instructed every new com­
manding officer who arrived in Europe
about alcoholism and how to deal with it 
successfully. Our program was enormous­
ly successful and had tremendous support
from the military high command. That
was an absolutely superb experience,
probably the most rewarding professional
experience of my life.
After I returned to this country,
President Reagan asked me to become
administrator of ADAMHA. The position
was somewhat tricky, because the three
Institutes (NIAAA, NIMH, and the
National Institute on Drug Abuse
[NIDA]) were not really very closely
associated with one another, intellectually
or philosophically. But I did have a won­
derful year­and­a­half at ADAMHA. 
AH&RW: What did you consider as
NIAAA’s main mission during your
tenure as the Institute’s director? 
Mayer: One thing I always have felt
strongly about is that alcoholism is a seri­
ous organic disease, which is obvious,
considering the liver or brain damage
involved. I was convinced that being an
alcoholic was purely accidental and that
personality, character, intelligence, or
culture determined the development of
alcoholism no more than it did the devel­
opment of disorders such as diabetes or
chronic heart disease. I also felt that the 
field of alcoholism needed legitimacy
among the rest of the medical profession.
As long as it didn’t have legitimacy—and
it still doesn’t in many areas—it was very
difficult for alcoholic patients to get the 
B e f o r e b e i n g a p p o i n t e d a d m i n i s t r a ­
t o r o f A D A M H A i n 1 9 8 1 , W I L L I A M E . 
MA Y E R , M. D. , h e l d s e v e r a l h i g h ­l e v e l
h e a l t h c a r e p o s t s i n C a l i f o r n i a .
C o n c u r r e n t w i t h b e i n g A D A M H A
a d m i n i s t r a t o r , D r . M a y e r s e r v e d a s
d i r e c t o r o f N I A A A . H e s u b s e q u e n t l y
w a s a p p o i n t e d A s s i s t a n t U. S.
S e c r e t a r y o f D e f e n s e f o r H e a l t h
A f f a i r s a n d l a t e r s e r v e d a s d i r e c t o r 
o f t h e D e p a r t m e n t o f M e n t a l H e a l t h
i n C a l i f o r n i a b e f o r e r e t i r i n g i n 1 9 9 2 . 
treatment and long­term care they needed.
Consequently, I tried very hard to convince
people in government, in the bureaucracy,
in the medical profession, and among the
patients themselves that alcoholism was a
legitimate disease. I told them that alco­
holism was treatable, although as far as we
knew not curable (but neither are diabetes
or hypertension), and that we could man­
age it like other chronic diseases. That was
my main mission as NIAAA director and
as ADAMHA administrator. 
AH&RW: Where do you think NIAAA
had the strongest impact in the alcohol
field—in research or in public policy? 
Mayer: I think it was probably in research,
but I hasten to add that its support of treat­
ment programs was an absolutely crucial
achievement. Lurking in the background of
all discussions about alcoholism was the 
belief by many people in the power struc­
tures that if you were an alcoholic, you
were a bum and really didn’t deserve good
treatment. Alcoholics existed and some­
thing had to be done about them, but
nobody really wanted to be bothered.
Breaking down those old stereotypical and
prejudicial beliefs, especially among influ­
ential members of Congress and the
Administration, was terribly important, and
I think much of what NIAAA has done has 
helped along those lines. These efforts
have to continue because I think that alco­
holism and its treatment are still not estab­
lished parts of medicine.
But I also consider the research very
important and successful, especially with
respect to genetics, to the familial inci­
dence of alcoholism. For example, re­
searchers at the University of California,
San Diego, turned up some fascinating
linkages between alcoholic fathers and
sons who had alcohol problems. Unfortu­
nately, a lot of the genetic and familial
research is considered by some of the
more purist researchers as a kind of “soft”
social science research. But I think there 
has to be an element of that in alcohol 
research, because alcoholism does partly
manifest itself in behavioral and social 
terms, and some of the research in that
area has been extremely important. In
addition, the research conducted on alco­
hol metabolism and on FAS was fabulous. 
Finally, an achievement that I take a
great deal of pride in was in addressing the
problem of alcohol abuse and the rapidly
rising rate of deaths from alcohol­related
automobile crashes among adolescents.
NIAAA and the NCA started a program
throughout the United States in which high
schools that had programs designed by and
for their students to diminish alcohol abuse 
competed against each other. The best
program in each State was selected, and
the 50 winning teams convened for a
conference in Washington, DC. I think this
program was a marvelous example of what
Government can and should do, of how
Government can start focusing public
attention in a constructive way on a grow­
ing problem. And the problem has steadily
diminished since that time: Fewer adoles­
cents are being killed in alcohol­related
accidents, especially on graduation night. 
AH&RW: What do you consider the most
pressing problems for the next decades in
the alcohol field? 
Mayer: Early identification. The suscepti­
bility to alcoholism probably can be identi­
fied much earlier than we can do at this 
time, in adolescents perhaps even before
they drink any alcohol. There must be
biological markers by which it will be
possible to predict heightened susceptibility
to alcoholism. And to the people at risk, we
have got to say, “Look, it is not your fault;
you are not necessarily destined to become
alcoholic, but you are 10 times more likely
than your friend. Here is what you need to
be aware of.” We have got to develop a
special training and education program for
these people; they should be the principal
recipients of our best prevention efforts. 
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I also think NIAAA needs to be 
strongly and publicly involved in the
study and prevention of the consequences
of alcohol abuse—not alcoholism, but
alcohol abuse. Some really serious prob­
lems exist among people who abuse
alcohol. An incredible percentage of
people who commit crimes do so while
drinking, and a huge amount of family
violence and street violence is connected 
with alcohol. This association of alcohol 
with violence, family disruption, crime in
general, accidents, general health prob­
lems, and loss of productivity must be
addressed very aggressively.
When looking at these problems, how­
ever, there is a danger of getting alcohol
abuse mixed up with addictions to other
drugs. Of course some people will abuse
any drug they can get their hands on. But
I believe that there is a world of differ­
ence between alcoholism as a disease and 
the use and abuse of and dependency on
most other drugs. Therefore, I do not like
grouping alcohol and other drugs togeth­
er, and I do not think that measures de­
signed to help manage the chronic disease
of alcoholism necessarily can be applied
successfully in the management of addic­
tion to other drugs. A high percentage of
addicts and drug abusers have profound
characterological problems, whereas
alcoholics as a group include many people
who have demonstrated successful life 
patterns. I think in most cases, alcoholics
and drug abusers are different populations
and should be addressed separately. 
AH&RW: What specific characteristics
have allowed NIAAA to be so successful 
in advancing the alcohol field? 
Mayer: What is unique about NIAAA is
that the Institute has managed, albeit with
varying success from time to time, to
continue an advocacy and public activism,
with respect to educating the public about
alcohol, that has remained nonmoralistic,
and that, I think, has been extremely
healthy. I also think that the Institute has
been very good about publicizing research
results. This information effort needs to 
continue, because alcoholism still is seen
as a behavioral problem by a small but
significant portion of the public. 
AH&RW: Dr. Mayer, how would you
summarize your tenure at NIAAA? 
Mayer: It was an enormously rewarding
professional experience that contributed
greatly to my understanding of a huge
population of patients who need help, 
who often respond to help, who can be
managed like any chronically ill patients,
and who deserve the very best medically
and psychiatrically that we can give them. ■ 
ROBERT G. 
NIVEN, M.D. 
DIRECTOR, 1983–1985 
AH&RW: Dr. Niven, can you describe
briefly why you got involved in the alco­
hol field? 
Niven: What initially sensitized me to
addiction problems was having a friend in
high school whose parents both were
alcoholics and another friend in medical 
school who developed and ultimately died
of serious drug­dependency problems.
Later, as a resident in internal medicine at
the Mayo Clinic, I had to do a rotation in
the psychiatry department. There I began
to see that alcoholics and drug addicts
could be treated successfully. During my
rotation, the clinic’s alcoholism program
held a reunion of its “graduates.” I was
very impressed with, and intrigued by,
how well these people were doing in their
lives and how pleasant, happy, and re­
sponsible they were. They were very
different from the stereotypical view of
alcoholics. I later changed my specializa­
tion from internal medicine to psychiatry.
I often worked in chemical dependency
treatment units and found the patients a
very interesting group to work with.
Subsequently, chemical dependency
became my subspecialty for my entire
psychiatric career. 
AH&RW: Do you think that as a clini­
cian, you had a different perspective on
NIAAA and your position than directors
who came from a more research­oriented 
background? 
Niven: Perhaps I did have a slightly differ­
ent perspective than somebody with a pure
research background. But I strongly be­
lieve that ultimately, research will provide
the answers to alcohol problems. Being a
good clinician involves utilizing the best
scientific data available and pertinent to
the clinical issue at hand. It also involves 
applying the knowledge base both to a
given patient’s situation and to issues
beyond the individual patient, for example,
in the prevention field. Consequently, I 
believe in NIAAA’s research mission and 
consider it absolutely critical.
When I became NIAAA director, the
Institute was still undergoing its transition
from a prevention and treatment focus to a
research focus. One of the things I could
accomplish during my tenure was to
strengthen support for NIAAA’s research
mission in Congress and the Adminis­
tration. At that time, nonresearch groups
in the alcohol field, such as the lay public
and some prevention and treatment orga­
nizations, had mixed feelings about
whether NIAAA should be involved in 
research. They saw funding for research
gradually increase, whereas funding for
treatment services declined. That caused 
some animosity and skepticism toward
NIAAA in Congress and among the non­
research constituency. However, we were
able to overcome these negative percep­
tions, to strengthen our research activities,
to increase our budget, and to attract more
top­quality researchers to the intramural
and extramural programs. The involve­
ment of these researchers and of other 
nonresearch organizations helped the
Institute to grow at a time when skepti­
cism still persisted regarding whether
alcoholics even were worthy of treatment
and research. 
AH&RW: What do you consider were
NIAAA’s primary achievements during
the past 25 years? 
Niven: I think that the Institute’s primary
achievement was—through the research,
treatment, prevention, and epidemiologic
components of its activities—to build a
scientific knowledge base of information
about alcoholism. NIAAA also helped
establish the concept among a significant
portion of the public that alcoholism is a
major health problem, even a public
health problem. The Institute demonstrat­
ed that many alcoholics were treatable
and that some of the alcohol­related mor­
bidity and mortality, as well as some of
the horrendous economic costs that are 
consequences of alcohol and other drug
abuse, could be prevented.
These changes may not have been
very glamorous, but they were critical.
In my just over 20 years in the field, I
have seen enormous developments in the
acceptance—by the public, the Govern­
ment, and Government agencies—of
alcohol­related problems as a group
of treatable and preventable problems.
Society still is not where it should be with
respect to the overall perception of alco­
holism; there still is much work to do. In 
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fact, antialcoholism and antidrug abuse
treatment forces seem to be gaining
ground lately. Nonetheless, I think we
have made much progress. But although
NIAAA was a major player in bringing
about these changes, it also is important
to recognize that it was not the only play­
er; other groups and organizations also
contributed significantly to these efforts.
The continued collaboration among such
groups is essential if we are to continue
making maximal progress. 
AH&RW: As a clinician, do you think
that all the recent scientific advances 
already have affected the treatment of the
individual patient? 
Niven: I think that although alcohol research
is no longer in its infancy, it still is in its
childhood. Some neurobiological or genetic
studies still are in the early stages of devel­
opment and have not advanced sufficiently
to be applicable to the general treatment of
alcoholics. However, within the next
decade, researchers and clinicians should
be in a position to advance significantly the
treatment applicability of these technolo­
gies for a much broader patient population. 
AH&RW: What do you consider the most
pressing alcohol­related needs that the
alcohol field will face in the future? 
Before being appointed director
of NIAAA, ROBERT G. NIVEN, M. D.,
served as director of the Mayo
Medical School Alcohol and Drug
Abuse Teaching Program and of the
Mayo Clinic Adolescent Drug Abuse
Service. Dr. Niven currently is the
medical director of the Chemical 
Dependence Program in the Depart­
ment of Psychiatry at Harper Hospital
in Detroit, Michigan. In addition, he
is an associate clinical professor at
the Wayne State University School of
Medicine in Detroit. 
Niven: First, I think that we need to devel­
op better pharmacological agents to mini­
mize alcohol­induced pathology. By
minimizing or reversing the physiological
impact of alcohol and other drug overdoses
and intoxication, we can significantly
decrease alcohol­related morbidity and
mortality.
Second, we need to identify the genes
responsible for or involved in developing
tolerance and in developing the disease of
alcoholism. We also need to identify the
genes responsible for making particular
subgroups of alcoholics more or less
susceptible to certain complications of
alcoholism, such as Wernicke­Korsakoff’s
syndrome, liver disease, or pancreatitis.
Progress in this area would enable us to
identify people at risk for these disorders;
could open the doorway for more specific
interventions, including pharmacological
measures; and would ultimately allow us
to make another giant stride in reducing
alcohol­related morbidity and mortality.
Third, we still have a long way to go
in terms of preventing alcohol­related
problems, although we certainly have
made advances in that area. For example,
it was very encouraging to see that alco­
hol consumption declined for several
consecutive years and that we were mak­
ing some real progress in diminishing
alcohol­related automobile crashes. Un­
fortunately these developments seem to
have leveled off recently.
Another prevention area that needs
much more attention is the impact of
parental alcoholism and other forms of
drug dependence on the behavioral prob­
lems of children, in addition to the clini­
cal effects of FAS and the increased risk 
for alcoholism that children of alcoholics 
have. In my clinical practice, I constantly
see how alcohol abuse contributes to both 
domestic violence and the abuse and 
neglect of children. These problems still
are seriously underestimated, underdiag­
nosed, and undertreated even when they
are recognized. We need more education
about the consequences of parental alco­
hol abuse—for example, in the school
systems; among pediatricians; or in agen­
cies focusing on children, such as child
protective services.
In summary, I think we need to increase
the research on more effective prevention
strategies. I am convinced that alcohol
abuse still is a major underdiagnosed and
undertreated health problem and a major
contributor to health care costs. But I firmly
believe that many current deficiencies can
be changed for the better. 
Another issue that intrigues me as a
clinician is the individual variability that
exists in some alcohol­induced pathology.
I have seen people who drink 1 pint of
alcoholic beverages every day for 5 years
develop liver cirrhosis, whereas other
people drink more than that for 20 years
and still have perfectly normal liver func­
tions. There must be an explanation,
likely genetic, for these individual differ­
ences, and we need more research to
determine what it is. Such research also 
should include the analysis of the chemi­
cals in alcoholic beverages other than
alcohol itself. 
AH&RW: Ten years ago, you said that
you did not think that society could eradi­
cate alcoholism in your lifetime as it has
other diseases. Has the scientific progress
since then made you change that opinion? 
Niven: I still do not believe that substance 
abuse, particularly alcohol abuse, will
ever be eradicated completely. After all,
alcohol has been around since antiquity
and is produced so readily from a variety
of sources. But I do think that we can 
significantly reduce alcohol­related
pathology and alcoholism’s economic
burden on society. It will be a slow proc­
ess, because there are powerful worldwide
economic interests involved in producing
and selling alcoholic beverages. But if we
could reduce the alcohol problem to the
level of, for example, the heroin problem,
I think most people in the field would be
elated. As a clinician involved in chemical­
dependency treatment, I certainly am not
trying to denigrate the significance of the
heroin problem in our society, but it is
just many, many times less severe than
the alcohol problem. 
AH&RW: What kind of an impact did
your tenure at NIAAA have for you on a
more personal level? 
Niven: As with any other job, there were
both good and bad experiences. It was a
fascinating, albeit at times an incredibly
frustrating, job. It educated me about the
political processes connected with re­
search. Before I became NIAAA director,
I never really fully appreciated the signifi­
cance and the broad public health impact
that an agency such as NIAAA could
have. For example, after I had been at the
Institute for only 1 month, the health care
funding concept of diagnosis­related
groups (DRG)5 was implemented. As a
clinician, I realized that the DRG limits for
alcoholism treatment did not reflect the 
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reality of treatment services and that the
data on which the limits were based were 
seriously flawed. I think it would have
devastated the treatment field if we had not 
been successful in challenging the DRG
plans. Therefore, I felt very gratified per­
sonally when we were able to stop these
plans (while we developed better data) in
an enormous team effort of NIAAA staff,
of ADAMHA staff under ADAMHA 
administrator Robert Trachtenberg, of
people at NIDA and NIMH, and with
strong support from the treatment commu­
nity and from Betty Ford.6 
Another very personal advantage was
that the position allowed me to meet many
great people—researchers; the staff at
NIAAA; administrators, such as Robert
Trachtenberg; heads of other Institutes,
such as William Pollin at NIDA and 
Herbert Pardes at NIMH; or people with
NCA, the Children of Alcoholics Founda­
tion, and other organizations. These per­
sonal contacts were very rewarding, and
I value them to this day.
I also personally felt very pleased that I
was able, with a few other psychiatrists, to
facilitate an increased awareness of alcohol 
problems and the need for action to deal
with them in organized psychiatry. ■ 
ENOCH 
GORDIS, M.D. 
DIRECTOR, 1986–PRESENT 
AH&RW: Dr. Gordis, how did you first
become involved in the alcohol field? 
Gordis: It is amazing how fate propels
you into things that you never anticipated,
how you really can’t plan your future.
Starting in 1961 I had been working in
Dr. Vincent Dole’s laboratory at the
Rockefeller University in New York City.
During the 1950’s it was a leading labora­
tory in the study of fat metabolism, and I
started to work in that area. Around that 
time, however, Dr. Dole was invited to
replace the chairman of a meeting on New
York City’s drug problems. At this city­
5In the health care compensation model of diagnosis­
related groups, hospitals were paid a fixed amount for
the treatment of various categories of diseases, based
on the calculated length of stay of patients with these
diseases. The goal was to reduce above­average
hospital stays and thus control health care expenditures. 
6The wife of former U.S. President Gerald Ford. 
wide leadership conference, Dr. Dole
discovered that every participant had
opinions on the topic, but nobody had any
data. To him, that was not the way to deal
with such a public policy issue. Conse­
quently, he sought and got permission
from the president of Rockefeller Univer­
sity to study heroin addicts at the univer­
sity’s hospital, a project that eventually
led to the development of methadone
maintenance treatment for these patients.
The intellectual focus in Dr. Dole’s 
laboratory gradually shifted from fat
metabolism to addiction, which was a
very different kind of intellectual chal­
lenge. Consequently, when I completed a
project in fat metabolism in the mid­
1960’s and was looking for a new avenue
to explore, I began to consider the alcohol
issue. Dr. Marie Nyswander, a colleague
in the laboratory, introduced me to a close
friend of hers, Dr. Ruth Fox, who was a
physician in New York City and one of
the pioneers for the inclusion of alco­
holism treatment into medical practice.
Dr. Fox had introduced the alcohol­
sensitizing medication Antabuse® from 
Denmark and prescribed it to many clients
in her practice. Thus, while I was still at
Rockefeller University studying animal
models and alcohol withdrawal, I also
began to work with Dr. Fox in her prac­
tice to learn her approach to treatment.
That was the “accident” by which I
entered the alcohol field. As a youngster, I
hardly would have predicted that ultimate­
ly as an adult, I would study problems
related to alcoholism, but that is the kind of
surprise that life sometimes has in store.
In 1971 the opportunity arose to estab­
lish an alcoholism program at the city
hospital in Elmhurst, NY. The funds had
been provided to the hospital’s psychiatry
department by the State, but because at
that time there was still a strong disdain
for alcoholics, nobody wanted to start the
program. I think some of the members of
the department at the time felt that alco­
holics and addicts ought to be put on
some island and left there; a view, by the
way, that unfortunately might find some
sympathy in this country even today. So I
established and administered the program
in Elmhurst, where we treated some
15,000 patients during the next 14 years. 
AH&RW: What, in your opinion, were
the primary achievements of NIAAA
during the past 25 years? 
Gordis: One could list numerous impor­
tant scientific insights concerning treat­
ment, genetics, the development of animal 
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models, or the importance of neuro­
science. But I think what counts most is 
that NIAAA showed that research can 
make an important contribution to solving
the alcohol problem, that in fact it is an
indispensable element to solving the
alcohol problem. Alcoholism treatment
can be approached with the same scientif­
ic rationale and style as other areas of
medicine. It has stopped being a vaguely
formulated problem and instead gradually
has been brought into the mainstream of
medical science. The individual findings
are important, but the general recognition
that alcoholism can be studied with the 
most contemporary tools of science is the
contribution that stands out. 
AH&RW: Do you think that the academic
achievements in the alcohol field have 
translated into improved care for the
individual patient or a changed perception
of alcoholism by the public? 
Gordis: Scientific progress already has
affected the patients and the public in
some ways, and I think that it will contin­
ue to do so at a very accelerated pace
during the next 10 or 15 years. Obviously,
defining FAS has had a major public
health impact. And the knowledge that a
genetic component contributes to the
vulnerability to alcoholism has been 
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instrumental in forming the public’s
perception of alcoholism as a disease.
Also, in the last few years, the treat­
ment community has begun to recognize
the importance of measuring treatment
outcome and conducting proper clinical
trials using blinding, randomization,
placebos, and so on. We are entering an
era in which the treatment community
will be affected heavily by the results of
research, probably in the next 5 or 10
years. All these things are happening and
are supported strongly by NIAAA. 
AH&RW: One of your interests is the
interaction between science and public
policy. Do you think that the recognition
for the alcohol field in the public policy
arena has improved? 
Gordis: The interaction between science 
and public policy has brought mixed re­
sults over all. For example, during the
recent discussions of health care reform,
the importance and value of alcoholism
treatment clearly were recognized. The
details are not as important at this point as
the fact that alcoholism treatment would 
have been included in a reform package,
whatever its form. In fact, I believe that in
some places, it already is being considered
a part of the mainstream reimbursement
system without special caps or limitations.
These are very positive developments.
There also is a greater respect now in
Congress for the problems of alcohol
abuse. Legislation has been passed that
effectively demonstrates that change—
such as the 21­year minimum age for
alcohol use, with its impact on drinking
and driving. The rights of alcoholics also
were incorporated in legislation during the
last 20 years.
I believe that alcohol research served as 
the foundation for these changes. The
ongoing research activities saved us from
attacks on the concept of alcoholism as a
disease and helped shatter the idea of
alcoholism as “willful misconduct.” This 
probably was brought about not by any
single conclusion but by the general feel­
ing that the disease alcoholism is a puzzle
and that science is the way to solve it.
But there have been some setbacks as 
well. The alcohol field still does not com­
mand the same respect as other areas of
medicine. Some people once again consid­
er addiction just an excuse for misbehav­
ior, not a cause. And I think that part of the 
discussion about alcoholism in relation to 
disability also has been retrogressive.
Thus, the developments have been mixed,
but overall they represent progress. 
AH&RW: What do you consider the big
challenges for NIAAA in the next 25 years? 
Gordis: I believe that the direction that 
alcohol research is taking is excellent on
all fronts. However, we still are a small
field, considering the number of investi­
gators involved, and funding is not readily
available. Obviously it is preferable if an
institute or a scientific group is large and
diverse, because every field needs new
ideas. However, new ideas often are
proposed by young investigators who may
not get a chance to pursue them. That is
one of the challenges that we face. But I
think that as alcohol research continues to 
evolve and mature, it will produce both
interesting answers and new questions
that can attract new people.
Our major policy problem is that we
still have no significant lay constituency
for alcoholism. Other medical disciplines
have organizations, such as the American
Cancer Society, that are initiated or man­
aged either by the patients or their family
members and that mount campaigns for
funding to support research. That is not
yet happening in the alcohol field, al­
though some efforts are being made in
that direction. The lack of a lay constitu­
ency is perhaps our primary obstacle as
far as the public perception of alcoholism
is concerned. 
Another challenge for the future is to
erase the old public misperception that
although research may be very nice, we
basically already know how to treat alco­
holism effectively—all we have to do is
get patients to attend AA meetings or
therapy. In reality, however, it is quite the
opposite. Alcoholism treatment only has
limited effectiveness; many patients either
do not receive treatment, do not like the
treatment they receive, or relapse eventu­
ally. Although current treatment has a
positive cost­benefit ratio, we still have so
much more to learn. 
AH&RW: What makes alcohol research 
such an exciting field, and in which area
does your main interest lie? 
Gordis: My relationship with the different
areas of alcohol research is like a parent’s
relationship with his children—they all 
are different but he loves them equally.
Because of my training in internal
medicine and my laboratory science
background, I obviously have a persistent
interest in that side of our work. But I 
believe that top people in any discipline
have something to teach us, and it is a
mistake to cling tightly to one’s own area
of expertise and decide that that is the
only way for the field to go. Therefore,
areas such as the psychosocial sciences
also are very important for many reasons.
Besides, it is very hard to predict at any
given moment whence the next major
breakthrough will come. Thus, whether it
is molecular biology and genetics, the
economics of alcohol consumption, or
anything in between (such as treatment,
prevention, or toxicology), I consider all
these areas important.
Why is alcohol research so attractive?
Alcoholism affects so many facets of
society that one can make a contribution
to the field no matter what one’s back­
ground is. Whether researchers study
treatment and prevention or analyze the
molecular biology of some nerve cell
receptor, they all are doing something that
is vital to the field. There are not many
fields in which that is true, and I think
that is part of the appeal and attraction of
alcohol research for many people. What
also makes the field, and my position as
Institute director, very enjoyable is that
the challenges and questions in our sci­
ence are extraordinarily interesting and
solving them will benefit the public im­
mensely. Therefore, one feels that what
one is doing is intrinsically worthwhile.
Another challenging aspect of alcohol
research, which also is true in many other
areas of medicine, is that its fundamental
question is still not answered. That ques­
tion is, “What is the relationship between
this substance and this individual person
that enables the substance to dominate the 
person’s life to the exclusion of every­
thing else?” That is what we do not under­
stand and what we are trying to learn.
Once we understand this relationship,
there is hope that we can disrupt it. ■ 
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